Page 9 - TD-4-2
P. 9

Tumor Discovery





                                        EDITORIAL
                                        The transformative role of AI in cancer research



                                        Amancio Carnero *
                                                       1,2
                                        1 Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío (HUVR), Consejo
                                        Superior de Investigaciones Científicas, Universidad de Sevilla, Seville, Spain
                                        2 CIBERONC, Instituto de Salud Carlos III, Madrid, Spain



                                        1. AI in the management of complex cancer data
                                        Cancer research is inherently data-intensive. It integrates information from diverse
                                        domains such as genomics, proteomics, clinical records, and imaging, each providing
                                        unique insights into disease origins and progression. The volume and complexity of
                                        these data sets often exceed the capabilities of traditional analytical approaches. This
                                        is  where  artificial intelligence  (AI)  becomes  a  powerful ally.   AI excels at managing
                                                                                         1
                                        heterogeneous data sets. It processes raw data by performing essential tasks such as
                                        cleaning, normalization, and preprocessing. These steps are crucial, as cancer data sets
                                        often present issues such as missing data points and variations in format across studies
                                        and institutions. By automating these processes, AI reduces the risk of human error and
                                        speeds up the preparation of data for further analysis. Once preprocessed, the data must
                                        be analyzed to find patterns that can reveal biomarkers – indicators of disease presence
                                        or progression.  Machine learning algorithms, especially supervised and unsupervised
                                                    2
                                        learning models, are adept at this task. They can examine large amount of genomic and
                                        proteomic data to identify subtle patterns that correlate with specific types of cancer.  For
                                                                                                          3
                                        example, machine learning models can link genetic mutations to certain cancer types,
                                        uncovering biomarkers that might not be apparent through traditional techniques. These
                                        biomarkers are invaluable in a variety of contexts, including early detection, prognosis
                                        prediction, and therapeutic targeting. Furthermore, AI-based predictive models can
            *Corresponding author:
            Amancio Carnero             estimate a patient’s response to specific treatments, allowing for personalized cancer
            (acarnero-ibis@us.es)       therapy – a pillar of modern oncology. 4
            Citation: Carnero A. The      One of the most transformative applications of AI in cancer research lies in the
            transformative role of AI in   analysis of genomic sequencing.  Genomic data holds clues about the mutations that
                                                                  5
            cancer research. Tumor Discov.
            2025;4(2):1-3.              drive cancer. Decoding this information is essential to understanding the disease and
            doi: 10.36922/TD025040006   designing targeted interventions. Deep learning models have proven particularly effective
            Received: January 21, 2025  in this arena. Deep learning excels at identifying subtle genetic mutations that traditional
                                        statistical  methods  might miss. These algorithms  analyze  sequence  data  to identify
            Published online: March 10, 2025  new genes associated with cancer, annotate genetic variants, and infer their functional
            Copyright: © 2025 Author(s).   significance. By unraveling these genetic mysteries, researchers can identify potential
            This is an Open-Access article   drug targets, laying the groundwork for innovative therapies. In addition, AI helps in
            distributed under the terms of the
            Creative Commons Attribution   building complex models of biological pathways. These models reveal intricate networks
            License, permitting distribution,   of genes and proteins, offering insights into the underlying mechanisms of cancer. Such
            and reproduction in any medium,   pathways help researchers identify points of therapeutic intervention, paving the way for
            provided the original work is
            properly cited.             designing drugs that disrupt these networks and halt disease progression.
                                                                                                             6
            Publisher’s Note: AccScience   Medical imaging is another domain where AI is making significant progress.
            Publishing remains neutral with   Cancer diagnosis often relies on imaging technologies such as magnetic resonance
            regard to jurisdictional claims in
            published maps and institutional   imaging, computed tomography scans, and histopathological slides. Interpreting these
            affiliations.               images requires precision, as subtle features can indicate the presence or progression

            Volume 4 Issue 2 (2025)                         1                            doi: 10.36922/TD025040006
   4   5   6   7   8   9   10   11   12   13   14